Viyash Scientific Limited has informed the Exchange about Investor Presentation
VIYASH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Viyash Scientific Limited reported Q4 FY26 as its strongest quarter ever, with revenue of ₹9,200 million (up 19.1% YoY) and EBITDA of ₹2,001 million (up 63.8% YoY). EBITDA margins expanded significantly by 590 basis points to 21.7%. For full year FY26, revenue reached ₹34,203 million (up 13.8% YoY) with EBITDA of ₹7,025 million (up 59.6% YoY). The company successfully completed a transformative merger, integrating facilities, operations, and corporate functions into one unified platform. Net debt was reduced substantially from ₹4,511 million to ₹1,661 million, lowering Net Debt/EBITDA ratio from 1.0x to 0.2x. Management highlighted strong execution, improved operating leverage, and stated they are actively evaluating selective inorganic opportunities.
The substantial margin expansion and debt reduction demonstrate successful integration and operational improvements, which should be positive for shareholders. The significantly deleveraged balance sheet provides flexibility for future growth initiatives and selective acquisitions.